Recent Advances in Diagnostics in Transfusion Medicine

Dear Colleagues,

The field of Transfusion Medicine (TM) bridges the divide between blood donors and transfusion recipients, bringing blood products from the veins of healthy donors to the veins of patients.  Within this field, steeped in current good manufacturing processes, resides a collection of cellular therapy starting material and cellular therapy manufacturing—from transplantation to CAR-T cell therapy, gene therapy, and beyond.  Specific diseases—including autoimmune hemolytic anemia, sickle cell disease, and thrombotic thrombocytopenic purpura—lie within the purview of transfusion medicine—whether by laboratory diagnosis, transfusion therapy, or apheresis support.  The evolution of this specialty has witnessed a host of transformational events that have brought TM to its current iteration and poised it for future evolution.  This paper collection will focus on this evolution and include a variety of TM-focused topics discussing the past, present, and future of TM.

Dr. Minh Ha Tran
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• plasma alternatives
• factor concentrates and recombinant factors
• therapeutic plasma exchange
• cellular therapy with a focus on transfusion
• dependent thalassemia and sickle cell disease
• massive transfusion protocols and the emergence of whole blood for trauma
• anti-CD38 therapeutics and benchtop protocols